angiotensinconvert
enzym
zincmetallopeptidas
recent
identifi
member
reninangiotensin
system
degrad
angiotensin
ang
ii
ang
also
receptor
coronaviru
caus
sever
acut
respiratori
syndrom
sar
although
found
mani
tissu
highli
express
kidney
particularli
within
cell
proxim
tubul
decreas
level
vasoconstrictor
ang
ii
gener
vasodil
ang
may
protect
hypertens
renal
diseas
also
shown
prevent
acut
lung
injuri
shed
carboxyterminu
plasma
membran
cell
via
disintegrin
pathway
recent
solubl
detect
certain
biolog
fluid
includ
urin
plasma
cell
cultur
medium
enzymelink
immunosorb
assay
elisa
enzym
activ
assay
western
analysi
chapter
describ
detail
method
measur
enzym
activ
biolog
fluid
use
commerci
avail
synthet
fluorogen
substrat
provid
practic
costeffect
highthroughput
method
studi
potenti
role
shed
renal
cardiovascular
diseas
follow
reagent
must
prepar
brought
room
temperatur
start
assay
assay
buffer
mm
nmorpholino
ethanesulfon
acid
me
mm
nacl
adjust
ph
store
use
fluorogen
substrat
mcaalaproli
dnp
oh
anaspec
san
jose
ca
usa
catalog
number
reconstitut
mm
aliquot
sampl
store
least
month
least
month
nethylmaleimid
nem
mm
stock
doubledistil
phenylmethylsulfonyl
fluorid
pmsf
mm
stock
ethanol
aliquot
store
inhibitor
stock
also
call
provid
ore
pharmaceut
cambridg
usa
commerci
avail
calbiochem
san
diego
ca
usa
catalog
number
linear
form
stock
anaspec
catalog
number
ace
inhibitor
captopril
stock
sigmaaldrich
st
loui
mo
usa
standard
recombin
human
human
r
system
inc
minneapoli
mn
usa
catalog
number
recombin
mous
mous
r
system
inc
catalog
number
reconstitut
phosphatebuff
salin
pb
aliquot
stabl
least
month
least
month
micropl
black
fluoresc
micropl
reader
use
fluostar
galaxi
fluoromet
bmg
labtechnolog
durham
nc
usa
detect
emiss
nm
excit
nm
calcul
amount
work
reagent
use
add
fluorogen
substrat
proteas
inhibitor
assay
buffer
see
subhead
item
immedi
experi
gener
substrateassay
buffer
solut
achiev
concentr
follow
substrat
mm
nem
mm
pmsf
tabl
seventyf
micro
liter
substrateassay
buffer
solut
use
reaction
see
subhead
proteas
inhibitor
ad
prevent
substrat
hydrolysi
biolog
solut
standard
curv
gener
also
routin
add
proteas
inhibitor
assay
buffer
dilut
stock
human
mous
assay
buffer
concentr
ngml
standard
tabl
perform
serial
dilut
preced
standard
assay
buffer
standard
lowest
concentr
ngml
standard
blank
contain
instead
add
assay
buffer
alon
add
serial
dilut
standard
total
volum
enzymat
reaction
solut
see
tabl
achiev
final
concentr
ngml
set
plate
configur
black
micropl
standard
run
duplic
along
blank
control
contain
concentr
standard
two
well
use
total
activ
two
well
use
measur
activ
presenc
inhibitor
volum
individu
compon
per
well
shown
tabl
final
volum
enzymat
reaction
sequenc
addit
compon
plate
follow
add
total
enzymat
activ
reaction
well
micropl
inhibitor
well
instead
add
inhibitor
solut
stock
add
substrateassay
buffer
see
subhead
wellsadd
dilut
standard
well
therebi
achiev
total
reaction
volum
wellcov
plate
micropl
seal
film
follow
aluminum
foil
prevent
access
light
incub
plate
room
temperatur
h
plate
shaker
read
plate
fluoresc
reader
excit
wavelength
nm
emiss
wavelength
nmfor
determin
percentag
inhibit
activ
subtract
rel
fluoresc
unit
rfu
read
substrat
blank
read
well
activ
standard
determin
subtract
rfu
obtain
presenc
read
absenc
inhibitor
construct
standard
curv
plot
known
concentr
x
axi
standard
versu
rfu
axi
standard
fig
highli
linear
relationship
observ
rfu
concentr
human
r
p
r
p
fig
mous
r
p
fig
rang
detect
ngml
linear
equat
gener
human
mous
use
convert
rfu
concentr
human
mous
biolog
fluid
respect
hand
rfu
signal
reach
satur
concentr
greater
ngml
rfu
signal
becom
weak
undetect
concentr
less
ngml
rang
approxim
detect
limit
human
use
commerci
elisa
previous
report
rang
ngml
use
assay
measur
activ
human
urin
sampl
collect
renal
transplant
recipi
also
measur
activ
urin
sampl
male
fvbn
mice
without
streptozotocin
stz
induc
diabet
condit
cultur
medium
collect
primari
cultur
mous
proxim
tubular
pt
cell
h
incub
medium
mous
proxim
tubul
pt
cell
deriv
mice
grown
defin
medium
supplement
insulin
transferrin
selenium
ngml
hydrocortison
nm
nm
without
fetal
bovin
serum
fb
serum
previous
demonstr
contain
enzymat
activ
avoid
assay
biolog
sampl
collect
place
ice
aliquot
centrifug
g
min
supernat
collect
store
assay
perform
also
measur
activ
plasma
mice
without
stzinduc
diabet
blood
collect
chill
eppendorf
tube
plasma
separ
centrifug
g
min
store
time
assay
dilut
urin
sampl
least
plasma
sampl
assay
buffer
condit
cell
cultur
medium
undilut
sampl
use
well
plate
use
dilut
urin
eg
urin
plu
assay
buffer
dilut
plasma
plasma
plu
assay
buffer
undilut
cultur
medium
final
volum
enzymat
reaction
activ
fall
outsid
detect
limit
assay
lower
higher
dilut
may
requiredmeasur
activ
rfu
biolog
fluid
follow
experiment
procedur
describ
standard
see
subhead
calcul
concentr
rfu
biolog
fluid
use
linear
equat
gener
human
mous
appropri
fig
concentr
must
correct
dilut
factor
obtain
actual
concentr
undilut
sampl
concentr
biolog
fluid
typic
express
ngmlthe
amount
urinari
correct
creatinin
concentr
urin
sampl
control
urinari
dilut
report
creatinin
activ
cultur
medium
correct
cell
protein
amount
cultur
dish
report
protein
determin
intra
interassay
cv
activ
assay
biolog
sampl
result
support
reliabl
assay
three
sampl
human
mous
urin
mous
pt
cell
cultur
medium
mous
plasma
assay
six
separ
occas
duplic
mean
intraassay
cv
assay
human
urin
mous
urin
cell
cultur
medium
mous
plasma
mean
interassay
cv
valu
human
urin
mous
urin
cell
cultur
medium
mous
plasma
tabl
determin
extent
inhibit
activ
linear
form
anaspec
use
human
mous
specif
also
assess
regard
use
ace
inhibitor
captopril
concentr
human
mous
rang
ngml
enzymat
activ
measur
h
block
captopril
fig
inde
intern
control
one
may
add
captopril
anoth
ace
inhibitor
reaction
well
compon
assay
buffer
assay
strongli
inhibit
activ
human
wide
rang
concentr
recombin
enzym
ngml
degre
inhibit
rang
fig
high
concentr
human
ngml
potent
inhibitori
effect
compar
import
note
significantli
block
activ
mous
degre
inhibit
rang
fig
exert
inhibitori
effect
mous
activ
assay
inde
actual
enhanc
rfu
lower
level
mous
ngml
regard
pedersen
et
al
measur
dissoci
constant
ki
human
mous
activ
assay
substrat
report
ki
human
significantli
lower
ki
mous
suggest
higher
affin
human
inhibitori
effect
anoth
commerci
avail
conform
variant
cyclic
form
yet
test
assay
howev
ye
et
al
report
disulfid
bridg
cyclic
variant
bachem
inhibitori
effect
mous
rat
even
high
concentr
effect
inhibit
human
also
examin
dosedepend
effect
linear
form
activ
measur
h
use
mous
concentr
ngml
increas
concentr
significantli
enhanc
assay
characterist
inhibit
inde
highli
linear
relationship
activ
rfu
mous
concentr
observ
concentr
r
p
r
p
contrast
signific
inhibitori
effect
mous
activ
even
concentr
high
similarli
two
group
report
purchas
phoenix
pharmaceut
belmont
ca
usa
partli
ineffect
block
mous
recombin
mous
kidney
activ
howev
signific
inhibit
mous
observ
use
assay
buffer
maintain
ph
rat
pt
segment
use
linear
form
obtain
phoenix
pharmaceut
demonstr
inhibit
ang
format
ang
suggest
inhibit
rat
rat
kidney
cortex
ye
et
al
show
partli
inhibit
activ
measur
ph
accordingli
rel
poor
inhibit
rodent
mous
biolog
sampl
use
experi
activ
assay
human
biolog
fluid
either
use
determin
concentr
fluorogen
substrat
lower
use
assay
studi
effect
variou
substrat
concentr
rang
mous
enzym
activ
fig
low
substrat
concentr
mous
activ
reduc
valu
obtain
substrat
concentr
fig
hand
highli
linear
relationship
activ
rfu
concentr
observ
substrat
concentr
r
p
r
p
detect
limit
ngml
fig
accordingli
assay
biolog
sampl
routin
use
least
substrat
although
use
substrat
concentr
would
accept
howev
would
recommend
use
substrat
concentr
lower
necessari
incub
sampl
h
prior
measur
fluoresc
address
question
measur
activ
differ
time
point
h
incub
mous
concentr
rang
ngml
fig
timedepend
increas
activ
observ
mous
concentr
h
incub
rfu
signal
reach
satur
mous
concentr
ngml
linear
detect
rang
h
incub
ngml
fig
contrast
h
incub
time
linear
relationship
still
exist
activ
concentr
mous
ngml
fig
thu
detect
limit
assay
h
incub
extend
ngml
r
p
although
rfu
valu
significantli
lower
concentr
see
fig
lab
routin
select
h
incub
time
assay
sinc
activ
biolog
sampl
studi
within
h
detect
limit
ie
ngml
rel
high
protein
level
biolog
fluid
interest
incub
time
reduc
short
h
note
use
assay
perform
endpoint
rfu
measur
calcul
protein
concentr
standard
curv
typic
record
valu
ngml
biolog
fluid
activ
per
se
activ
also
report
rfu
per
volum
sampl
per
unit
time
rfumlmin
rfumlh
present
data
enzymat
activ
plate
read
fluoresc
reader
kinet
mode
maximum
veloc
v
max
rfumin
sampl
determin
adjust
inhibitorcontain
well
specif
activ
pmolemin
calcul
adjust
v
max
use
convers
factor
pmolrfu
determin
calibr
standard
curv
construct
use
fluoresc
peptid
fragment
mcaproleuoh
bachem
bubendorf
switzerland
catalog
number
final
enzymat
activ
biolog
fluid
correct
sampl
dilut
factor
express
pmolemlmin
pedersen
et
al
report
activ
assay
human
rat
mous
highli
phdepend
maxim
hydrolysi
rate
substrat
assay
buffer
ph
minim
activ
ph
use
assay
buffer
ph
activ
assay
recommend
measur
ph
biolog
sampl
prior
conduct
assay
limit
effect
ph
biolog
sampl
assay
advis
dilut
sampl
assay
buffer
much
possibl
measur
plasma
activ
avoid
chelat
edta
blood
collect
tube
recommend
sinc
chelat
could
inhibit
activ
metallopeptidas
urin
sampl
may
signific
background
fluoresc
nm
exampl
undilut
urin
sampl
mice
gene
delet
typic
obtain
background
fluoresc
read
greater
rfu
urin
assay
autofluoresc
may
interfer
fluoresc
signal
reduc
abil
detect
suggest
dilut
urin
sampl
eg
wildtyp
mice
typic
dilut
urin
sampl
assay
buffer
freezethaw
biolog
fluid
affect
activ
measur
activ
sampl
human
mous
urin
mous
pt
cell
cultur
medium
mani
three
freezethaw
cycl
interestingli
found
signific
differ
activ
freezethaw
cycl
three
sampl
categori
data
shown
p
nonetheless
biolog
sampl
like
prudent
restrict
use
repetit
freezethaw
assay
furthermor
recommend
repetit
freez
thaw
recombin
protein
found
activ
significantli
lost
second
freezethaw
cycl
previou
studi
report
urinari
activ
enhanc
renal
transplant
patient
diabet
use
enzym
activ
assay
preliminari
data
also
found
incub
mous
pt
cell
high
glucos
concentr
enhanc
activ
cultur
medium
suggest
increas
shed
cell
membran
data
shown
accordingli
determin
high
glucos
concentr
alon
affect
assay
shown
fig
activ
mous
pt
cell
cultur
medium
high
glucos
concentr
mm
significantli
differ
medium
normal
glucos
concentr
mm
p
n
also
studi
effect
increas
concentr
creatinin
sigmaaldrich
urea
sigmaaldrich
assay
sinc
substanc
rel
abund
urin
use
mous
found
neither
creatinin
mm
urea
mm
signific
effect
activ
ad
assay
buffer
fig
c
final
sinc
report
correl
urinari
protein
urinari
level
examin
effect
exogen
albumin
activ
assay
experi
increas
concentr
albumin
cohn
fraction
v
sigmaaldrich
catalog
number
ad
urin
sampl
mice
gene
delet
activ
measur
follow
incub
increas
concentr
mous
ngml
experi
averag
albumin
concentr
urin
sampl
mice
gene
delet
shown
fig
addit
exogen
albumin
effect
activ
